6k enter trial to test recombinant BCG vaccine

Some 6,000 “high-risk” individuals, including frontline healthcare workers and close contacts of infected patients, will undergo tests to determine if a recombinant Bacille Calmette-Guerian (BCG) vaccine can boost human immunity against Covid-19.

from Pune News, Latest Pune News Headlines & Live Updates - Times of India https://timesofindia.indiatimes.com/city/pune/6000-enter-trial-to-test-recombinant-bcg-vaccine-against-covid-19/articleshow/75307117.cms

Comments

Popular posts from this blog

Pune: Don't travel to spots prone to heavy showers

PMC to redraw containment zone map after June 30